spiropentaneacetic acid has been researched along with Asthma in 1 studies
*Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrés-Martín, A; Ballester-Asensio, E; Batlles-Garrido, J; Bosque-García, M; Caballero-Rabasco, MA; Campos-Alonso, E; de Atauri, ÁG; de Mir-Messa, I; Del Mar Folqué-Giménez, M; Del Río-Camacho, G; Freixa-Benavente, A; Gaboli, M; Garriga-Baraut, T; Gómez-Pastrana, D; López-Neyra, A; Lozano-Blasco, J; Martínez-Pardo, L; Mazón-Ramos, Á; Moreno-Galarraga, L; Navarro-Morón, J; Nieto-Cid, M; Nieto-García, A; Penín-Antón, M; Plaza-Martín, AM; Rivas-Juesas, C; Romero-García, R; Sánchez-Mateos, M; Sanz-Santiago, V; Torres-Borrego, J; Tortajada-Girbés, M; Valdesoiro-Navarrete, L; Valenzuela-Soria, A; Vázquez-Rodríguez, E | 1 |
1 other study(ies) available for spiropentaneacetic acid and Asthma
| Article | Year |
|---|---|
Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in Spain.
Topics: Anti-Asthmatic Agents; Asthma; Child; Cost-Benefit Analysis; Humans; Omalizumab; Quality of Life; Retrospective Studies; Spain; Treatment Outcome | 2023 |